To determine whether prostaglandins are involved in circulatory homeostasis in congestive heart failure, we measured plasma levels of the metabolites of vasodilator prostaglandins I2 and E2 in 15 patients with severe chronic heart failure. Mean circulating levels of both metabolites were 3 to 10 times higher than those in normal subjects. Plasma levels of both metabolites correlated directly with plasma renin activity and plasma angiotensin II concentrations (r = 0.64 and 0.84, respectively). Individual serum sodium concentrations were inversely correlated with levels of prostaglandin E2 metabolites (r = -0.92, P less than 0.001) and plasma renin activity (r = -0.69, P less than 0.02). Of 23 patients with severe heart failure challenged with indomethacin (an inhibitor of prostaglandin synthesis), the 9 with hyponatremia had significant decreases in the cardiac index (1.99 +/- 0.12 to 1.72 +/- 0.13 liters per minute per square meter of body-surface area, P less than 0.001) and significant increases in the pulmonary capillary wedge pressure (17.4 +/- 2.0 to 24.0 +/- 1.9 mm Hg, P less than 0.001) and systemic vascular resistance (1882 +/- 239 to 2488 +/- 315 dyn x sec x cm-5, P less than 0.001), whereas the 14 patients with a normal serum sodium concentration had no significant hemodynamic changes. We conclude that both vasoconstrictor (renin-angiotensin) and vasodilator (prostaglandin) mechanisms are operative in patients with heart failure complicated by hyponatremia and that these mechanisms interact to modulate circulatory homeostasis.
This article has been cited by other articles:
Dimopoulos, K., Diller, G.-P., Petraco, R., Koltsida, E., Giannakoulas, G., Tay, E. L., Best, N., Piepoli, M. F., Francis, D. P., Poole-Wilson, P. A., Gatzoulis, M. A.
(2009). Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur Heart J
0: ehp495v1-ehp495
[Abstract][Full Text]
Chatterjee, K.
(2009). Analytic Review: Hyponatremia in Heart Failure. J Intensive Care Med
24: 347-351
[Abstract]
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G.F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., Teo, K., Warren, S. R., for the WATCH Trial Investigators,
(2009). Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial. Circulation
119: 1616-1624
[Abstract][Full Text]
Knobloch, K., Bedair, H., Uehara, K., Fu, F. H., Huard, J.
(2008). Letter to the Editor * Authors' Response. Am J Sports Med
36: e5-e7
[Full Text]
Bockenhauer, D., Cruwys, M., Kleta, R., Halperin, L.F., Wildgoose, P., Souma, T., Nukiwa, N., Cheema-Dhadli, S., Chong, C.K., Kamel, K.S., Davids, M.R., Halperin, M.L.
(2008). Antenatal Bartter's syndrome: why is this not a lethal condition?. QJM
101: 927-942
[Abstract][Full Text]
Muthumala, A., Drenos, F., Elliott, P. M., Humphries, S. E.
(2008). Role of {beta} adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis. Eur J Heart Fail
10: 3-13
[Abstract][Full Text]
Gheorghiade, M., Rossi, J. S., Cotts, W., Shin, D. D., Hellkamp, A. S., Pina, I. L., Fonarow, G. C., DeMarco, T., Pauly, D. F., Rogers, J., DiSalvo, T. G., Butler, J., Hare, J. M., Francis, G. S., Stough, W. G., O'Connor, C. M.
(2007). Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial. Arch Intern Med
167: 1998-2005
[Abstract][Full Text]
Cui, J., McQuillan, P., Momen, A., Blaha, C., Moradkhan, R., Mascarenhas, V., Hogeman, C., Krishnan, A., Sinoway, L. I.
(2007). The role of the cyclooxygenase products in evoking sympathetic activation in exercise. Am. J. Physiol. Heart Circ. Physiol.
293: H1861-H1868
[Abstract][Full Text]
Juhlin, T., Erhardt, L. R., Ottosson, H., Jonsson, B. A.G., Hoglund, P.
(2007). Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. Eur J Heart Fail
9: 191-196
[Abstract][Full Text]
Massie, B. M.
(2005). Aspirin Use in Chronic Heart Failure: What Should We Recommend to the Practitioner?. J Am Coll Cardiol
46: 963-966
[Abstract][Full Text]
Mann, D. L., Bristow, M. R.
(2005). Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond. Circulation
111: 2837-2849
[Full Text]
Klein, L., O'Connor, C. M., Leimberger, J. D., Gattis-Stough, W., Pina, I. L., Felker, G. M., Adams, K. F. Jr, Califf, R. M., Gheorghiade, M., for the OPTIME-CHF Investigators,
(2005). Lower Serum Sodium Is Associated With Increased Short-Term Mortality in Hospitalized Patients With Worsening Heart Failure: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study. Circulation
111: 2454-2460
[Abstract][Full Text]
Juhlin, T., Bjorkman, S., Gunnarsson, B., Fyge, A., Roth, B., Hoglund, P.
(2004). Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors. Eur J Heart Fail
6: 909-916
[Abstract][Full Text]
Scott, A. C., Wensel, R., Davos, C. H., Georgiadou, P., Ceri Davies, L., Coats, A. J.S., Francis, D. P., Piepoli, M. F.
(2004). Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure. Eur Heart J
25: 1806-1813
[Abstract][Full Text]
Shah, S U, Anjum, S, Littler, W A
(2004). Use of diuretics in cardiovascular diseases: (1) heart failure. Postgrad. Med. J.
80: 201-205
[Abstract][Full Text]
Meune, C., Mourad, J.-J., Bergmann, J.-F., Spaulding, C.
(2003). Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance. Journal of Renin-Angiotensin-Aldosterone System
4: 149-154
[Abstract]
Shlipak, M. G.
(2003). Pharmacotherapy for Heart Failure in Patients with Renal Insufficiency. ANN INTERN MED
138: 917-924
[Abstract][Full Text]
Meune, C., Mahe, I., Mourad, J.-J., Cohen-Solal, A., Levy, B., Kevorkian, J.-P., Jondeau, G., Habib, A., Lebret, M., Knellwolf, A.-L., Simoneau, G., Caulin, C., Bergmann, J.-F.
(2003). Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. Eur J Heart Fail
5: 271-279
[Abstract][Full Text]
Zhang, Z.-H., Wei, S.-G., Francis, J., Felder, R. B.
(2003). Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am. J. Physiol. Regul. Integr. Comp. Physiol.
284: R916-R927
[Abstract][Full Text]
Kopp, U. C., Cicha, M. Z., Smith, L. A.
(2003). Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin. Am. J. Physiol. Regul. Integr. Comp. Physiol.
284: R116-R124
[Abstract][Full Text]
Zeuke, S., Ulmer, A. J, Kusumoto, S., Katus, H. A, Heine, H.
(2002). TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res
56: 126-134
[Abstract][Full Text]
Spieker, L. E., Ruschitzka, F. T., Luscher, T. F., Noll, G.
(2002). The management of hyperuricemia and gout in patients with heart failure. Eur J Heart Fail
4: 403-410
[Full Text]
Scott, A. C., Wensel, R., Davos, C. H., Kemp, M., Kaczmarek, A., Hooper, J., Coats, A. J.S., Piepoli, M. F.
(2002). Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control. Circulation
106: 214-220
[Abstract][Full Text]
Feenstra, J., Heerdink, E. R., Grobbee, D. E., Stricker, B. H. Ch.
(2002). Association of Nonsteroidal Anti-inflammatory Drugs With First Occurrence of Heart Failure and With Relapsing Heart Failure: The Rotterdam Study. Arch Intern Med
162: 265-270
[Abstract][Full Text]
Krumholz, H. M., Chen, Y.-T., Radford, M. J.
(2001). Aspirin and the Treatment of Heart Failure in the Elderly. Arch Intern Med
161: 577-582
[Abstract][Full Text]
Abassi, Z., Brodsky, S., Gealekman, O., Rubinstein, I., Hoffman, A., Winaver, J.
(2001). Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. Am. J. Physiol. Renal Physiol.
280: F43-F53
[Abstract][Full Text]
Stys, T., Lawson, W. E., Smaldone, G. C., Stys, A.
(2000). Does Aspirin Attenuate the Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Heart Failure?. Arch Intern Med
160: 1409-1413
[Abstract][Full Text]
Cowie, M R, Wood, D A, Coats, A J S, Thompson, S G, Suresh, V, Poole-Wilson, P A, Sutton, G C
(2000). Survival of patients with a new diagnosis of heart failure: a population based study. Heart
83: 505-510
[Abstract][Full Text]
Page, J., Henry, D.
(2000). Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem. Arch Intern Med
160: 777-784
[Abstract][Full Text]
Guazzi, M., Spaulding, C., Charbonnier, B., Cohen-Solal, A., Juilliere, Y., Kromer, E. P., Benhamda, K., Cador, R., Weber, S.
(1999). Hemodynamic Interaction of Aspirin With Enalapril • Response. Circulation
100
: e141-e142
[Full Text]
Pacher, R., Stanek, B.
(1999). Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience. Eur J Heart Fail
1: 263-268
[Full Text]
Mann, D. L.
(1999). Mechanisms and Models in Heart Failure : A Combinatorial Approach. Circulation
100: 999-1008
[Full Text]
Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., Uchida, K., Arimura, K.-i., Egashira, K., Takeshita, A.
(1999). Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium. Circ. Res.
85: 357-363
[Abstract][Full Text]
Katz, S. D., Radin, M., Graves, T., Hauck, C., Block, A., LeJemtel, T. H., for the Ifetroban Study Group,
(1999). Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with enalapril. J Am Coll Cardiol
34: 170-176
[Abstract][Full Text]
Farquhar, W. B., Kenney, W. L.
(1999). Age and renal prostaglandin inhibition during exercise and heat stress. J. Appl. Physiol.
86: 1936-1943
[Abstract][Full Text]
Leor, J., Reicher-Reiss, H., Goldbourt, U., Boyko, V., Gottlieb, S., Battler, A., Behar, S.
(1999). Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol
33: 1920-1925
[Abstract][Full Text]
Matsumoto, T., Wada, A., Tsutamoto, T., Omura, T., Yokohama, H., Ohnishi, M., Nakae, I., Takahashi, M., Kinoshita, M.
(1999). Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. Am. J. Physiol. Heart Circ. Physiol.
276: H1935-H1942
[Abstract][Full Text]
Farquhar, W. B., Morgan, A. L., Zambraski, E. J., Kenney, W. L.
(1999). Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J. Appl. Physiol.
86: 598-604
[Abstract][Full Text]
Abraham, W. T.
(1998). Pharmacologic Management of Chronic Heart Failure: A Review. SEMIN CARDIOTHORAC VASC ANESTH
2: 168-190
[Abstract]
Cowburn, P. J., Cleland, J. G.F., McArthur, J. D., MacLean, M. R., Dargie, H. J., McMurray, J. J.V., Morton, J. J.
(1998). Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction. Cardiovasc Res
39: 563-570
[Abstract][Full Text]
Ferrari, R.
(1998). Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res
37: 554-559
[Full Text]
Lang, C. C., Chomsky, D. B., Butler, J., Kapoor, S., Wilson, J. R.
(1997). Prostaglandin production contributes to exercise-induced vasodilation in heart failure. J. Appl. Physiol.
83: 1933-1940
[Abstract][Full Text]
Eichhorn, E. J., Bristow, M. R.
(1996). Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure. Circulation
94: 2285-2296
[Abstract][Full Text]
Packer, M.
(1995). Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?. Circulation
92: 1379-1382
[Full Text]
Prasad, K., Kalra, J., Bharadwaj, L.
(1993). Cardiac Depressant Effects of Oxygen Free Radicals. ANGIOLOGY
44: 257-270
[Abstract]
Panciroli, C., Galloni, G., Oddone, A., Marangoni, E., Masa, A., Cominesi, W. R., Caizzi, V., Pezzi, C., Belletti, S., Comalba, C., Orlandi, M.
(1990). Prognostic Value of Hyponatremia in Patients with Severe Chronic Heart Failure. ANGIOLOGY
41: 631-638
[Abstract]
Gurwitz, J. H., Avorn, J., Ross-Degnan, D., Lipsitz, L. A.
(1990). Nonsteroidal Anti-inflammatory Drug--Associated Azotemia in the Very Old. JAMA
264: 471-475
[Abstract]
METTAUER, B., ROULEAU, J.-L., BICHET, D., JUNEAU, C., KORTAS, C., BARJON, J.-N., de CHAMPLAIN, J.
(1986). Sodium and Water Excretion Abnormalities in Congestive Heart Failure: Determinant Factors and Clinical Implications. ANN INTERN MED
105: 161-167
[Abstract]
PACKER, M., LEE, W. H., MEDINA, N., YUSHAK, M.
(1986). Influence of Renal Function on the Hemodynamic and Clinical Responses to Long-Term Captopril Therapy in Severe Chronic Heart Failure. ANN INTERN MED
104: 147-154
[Abstract]
Previous
